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Intervention PBF SBF PVR:SVR PBFl SBF 1 PVR:SVR'
Epi infusion2 13,5' 20.8' +68 13.8' 14.5' -75
Bicarbonate3 9,2' 13.5' -4.5 10.2' 16.6' -04
Ca chloride4 7.9' 16.8' +2.6 12.64' lB.7' -1.7
Epi bolus5 941' ~6BB' -B8.8'
V Mohan Reddy, John R, Liddicoat, Jeffrey R, Fineman, Roger Chang, Judith
R, Klein, Frank L. Hanley, University of California, San FranCISco, CA
Neonatal and infant patients (pts) with single ventricle physiology (SVPI fol-
lowing bypass, for e,g, pts after stage I repair of hypoplastic left heart syn-
drome (HLHSI, often suffer from hemodynamic instability early after surgery,
Specific hemodynamic effects of pharmacologic resuscitation are poorly un-
derstood, To examine these issues a model of SVP was created in fetal
lambs: a Damus procedure was performed in fetal lambs using a 10 mm
ePTFE tube graft and the main pulmonary artery was ligated distally, Pul-
monary blood flow (PBF) was provided by creating a 6 mm systemic to pul-
monary artery shunt. Neonatal lambs with SVP were delivered normally at
term, At 48 hours after birth the lambs (n = 10) were instrumented and mon-
itored. Ultrasonic flow probes were placed on the aorta and the shunt to
measure systemic blood flow (SBF) and PBF. Interventions were performed
In random order before and after cardiopulmonary bypass and a 30 min pe-
riod of hypothermic circulatory arrest to mimic the clinical setting e,g, stage I
repair of HLHS. The effects on systemic and pulmonary vascular resistances
(SVR and PVR), PBF, and SBF are shown below
Value of Visualizing Atherosclerotic Plaques on
the Thoracic Aorta by Transesophageal
Echocardiography in Conjunction with
Pharmacologic Stress
Magdy lsmaeil, Theodor Trusevich, Shashikumar Bellur, Sheri Y Nottestad, R.
Stefan Kiesz, Fathy Maklady, Miguel Zabalgoitia. The University of Texas Health
Science Center, San Antonio, TX
1901-1091
ABSTRACfS 31A
Detection of atherosclerotic plaques within the thoracic aorta (TA) by trans-
esophageal echocardiography(TEE) has been shown to be a useful marker to
detect coronary artery disease (CAD). Dobutamine (Dob) stress echocardio-
graphy can induce segmental wall rnotion abnormalities (SWMA) in the pres-
ence of CAD. To determine the value of visualizing atherosclerotic plaques
on the TA in conjunction with Dob-TEE, 60 pts (54 rnales, 6 females; rnean
age 59 ± 13 yrs) with chest pain syndrome were studied. All pts underwent
coronary angiography. Dob was infused in 3-min increments from 5 to 40
mcglkglmin, Dob-TEE was considered positive if new or worsening of previ-
ously present SWMA were noted. Atherosclerotic plaques visualized on TA
were divided into simple and complex lesions. Simple lesions were defined
as intimal thickening or luminal irregularities, and complex lesions were pro-
truding, ulcerated or mobile plaques noted. Results: Significant CAD (2:50%
stenosis) was present in 49 pts and 11 pts had normal or non-significant
disease. Sensitivity (SE), specificity (SP). positive (+PV). negative (-PV) pre-
dictive values, and diagnostic accuracy (DA) are:
13) the identification of aortic aneurysm, TEE and autopsy grading of lesion
characteristics have excellent agreement when allowing for one category of
variation. The clinical relevance of this grading system requires further study.
Fetal Model of Single Ventricle Physiology:
Hemodynamic Effects of Epinephrine, Sodium
Bicarbonate, and Calcium Chloride
1901-1071
The TA showed atherosclerotic plaques in 45 of 49 pts with positive Dob-
TEE and it was free of disease in 9 of 11 pts with negative Dob-TEE (90%
agreement). The presence of complex lesions was significantly higher in pts
with multivessel disease (MVD) (21 of 32 pts 66%) than in those with single
vessel disease (SVD) (3 of 17 pts 18%), p < 0.01. While simple lesions were
more common in SVD (11 of 17 pts 65%) than in MVD (9 of 32 pts 28%), p
< 0.01. In conclusion, TA-TEE and Dob-TEE highly concur in detecting CAD.
Visualization of complex lesions on TA-TEE before Dob-TEE should alert for
the possibility of MVD.
Values represent percent increase or decrease from baseline. 1: post bypass,' 2:
epinephrine O. 1 /lglkglrnin; 3: sodium bicarbonate 2 mEqlkg 4: calcium chloride 10
mglkg; 5: epinephrine 1 in 10,000: 0.05 mllkg, ' P < 0.05.
In summary this is the first reported model which provides a useful tool
to study neonatal SVP Epinephrine infusion, sodium bicarbonate bolus, and
calcium chloride bolus increased both PBF and SBF. Epinephrine bolus even
at half the recommended code dose caused a tremendous increase in PBF
and severe decrease in systemic blood flow causing metabolic acidosis. On
average it took 5 min for the flows to return to base line values. This suggests
that epinephrine boluses should be used judiciously and probably be consid-
erably smaller in the management of patients with SVP Calcium chloride had
a good inotropic effect without significant effect on PVR:SVR ratio.
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Atheromatous Disease of the Thoracic Aorta: A
Transesophageal Echocardiography and
Autopsy Correlative Study
Alexander M.A. Schabauer, Peter C. Spittell, William D. Edwards, Bijoy
K. Khandheria. Mayo Clinic, Rochester- MN
Transesophageal echocardiography (TEE) is widely used for the evaluation
of thoracic aortic pathology, most recently atheromatous disease. Unfortu-
nately, there have not been any studies correlating TEE and autopsy find-
ings of atheroma to validate this use of the technique. Also, the TEE grading
systems for aortic atheromatous disease currently in use have not been es-
tablished to parallel pathologic grading systems, nor has their clinical signif-
icance been tested.
We retrospectively evaluated all patients who underwent TEE at our institu-
tion between 1988 and 1993 and subsequently underwent autopsy within 30
days of the TEE study. We identified 13 patients with adequate thoracic aortic
tissue available for pathologic analysis who also had a complete TEE exami-
nation of either the ascending, arch or descending thoracic aortic segments.
Among these there were 21 complete tissue segments available which had
been adequately imaged. All segments were reviewed and compared with
respect to: (1) surface area and pattern of atheroma, (2) area and pattern
of calcification, (3) depth of mural ulceration, and (4) type and description
of mural thrombus; also (5) measurements of maximum wall thickness, (6)
sizing of any aneurysm, and (7) characterization of any dissection.
Significant correlations were found using this detailed grading system for
surface area of atheroma (kappa test, K = 0.29 ± 0.261, wall thickness (corre-
lation, r = 0.56). correct identification of the one ascending aortic aneurysm,
and absence of dissection or mural thrombus. The correlations for pattern
of atheroma, area and pattern of calcification and depth of ulceration did not
reach statistical significance. However, there was an 86 to 100% agreement
for these lesion characteristics when allowing for 1 category of variation.
Conclusions; There is a good correlation between TEE and autopsy find-
ings with respect to: (1) atheroma surface area, (2) aortic wall thickness, and
Three-Dimensional Ultrasound Can Accurately
Reconstruct Intravascular Thrombi: In Vitro
Validation
Myung-Yong Lee, Neil J. Weissman, Leng Jiang, Tracy Svizzero, Arthur E. Weyman,
Robert A. Levine. Massachusetts General Hospital, Boston, MA
High-frequency ultrasound can potentially display gross morphologic
changes during thrombus formation and lysis. Current intravascular ultra-
sound (IVUS) devices, however, provide only 2-dimensional cross-sectional
images with limited overall appreciation of thrombus size and 3-dimensional
(3D) configuration. The purpose of this study was to explore the ability of
3D reconstruction of serial ultrasound images to provide a quantitative as-
sessment of intravascular thrombi. We therefore imaged 11 arterial thrombi
of varying shape and volume (10 to 116 mm3). To avoid thrombus disrup-
tion, we used an epivascular approach (also suitable for transvenous imag-
ing) with a 20 MHz IVUS catheter withdrawn at 1 mm/sec. A 3D voxel image
intensity data set was reconstructed, and thrombus volume was semiauto-
matically extracted based on its intensity. Calculated volume was compared
with directly measured values by volume displacement in a miniature cylin-
der.
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Longitudinal section of 3D
reconstruction
Results; 3D reconstruction provided previously unobtainable longitudinal
and 3D views that improved spatial appreciation of thrombus size, shape and
channel formation. Calculated thrombus volumes agreed well with actual
volumes: y = 0.92x + 2.4, r = 0.98, SEE = 5 mm3, mean error = 1 ± 5 mm3
856 ± 207* 870 ± 243*
27.0 ± 5.1* 278 ± 4.1*
3767±229* 3718±120*
36.2 ± 6,4
101 ±7 109±6 87±6* 93±7*
867±164* 1319±299
268±3.7*
4581 ± 608 4771 ± 597
FR139317 RES-701-1 Nitroglycerin Plastaglandin El
200/Lglkglmin 100 /Lglkg/min 10 /Lglkg/min 0,4 /Lglkglmin
Endothelin Receptor Antagonists in a Beagle
Model of Pulmonary Hypertension: Contribution
to Possible Potential Therapy?
Baseline
* Significant difference between baseline and drug infusions at P < 0,05 levels. MSAP:
mean systemic arterial pressure. MPAP: mean pulmonary arterial pressure. SVR: sys·
temic vascular resistance. PVR: pulmonary vascular resistance
MSAP 106±5
(mmHg)
MPAP 332±59
(mmHg)
SVR Idynesl 4685 ± 439
s/em 5)
PVR{dynes/1237±441
s/em 5)
Conclusions: ETA receptor antagonists decrease pulmonary arterial pres-
sure in a beagle model and therefore may be clinically useful for therapy of
pulmonary hypertension.
in this model, U74389G attenuates the systolic and diastolic dysfunction of
myocardial stunning, most likely by protecting the lipid component of cell
membranes from peroxidation by oxygen-derived metabolites.
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Morihito Okada, Chojiro Yamashita, Kenji Okada, Masayoshi Okada. Kobe
University. Kobe, Japan
The idealvasodilator for pulmonary hypertension (PH) would decrease pul-
monary arterial pressure with minimal systemic hypotension. The present
study was undertaken to investigate the pharmacologic effect of endothelin
receptor antagonists on cardiopulmonary hemodynamics in an animal model
of PH. We recently developed a beagle model of PH which allows accurate
determination of cardiopulmonary hemodynamics and which is associated
with elevated plasma endothelin-1 concentrations similar to PH in humans.
Twelve beagles (PH, n = 6; and Control, n = 6) were studied during base-
line conditions and during right atrial infusion of FR139317 (the ETA recep-
tor antagonist). RES-701-1 (the ETB receptor antagonist). nitroglycerin, and
prostaglandin E1. PH was induced in experimental animals 8 weeks after
an injection of 3 mglkg dehydromonocrotaline. The table showed hemody-
namic values of PH beagles at baseline and during drug infusion. FR139317
lowered pulmonary and systemic arterial pressure both in pulmonary hyper-
tensive and control animals, with a significantly greater effect on pulmonary
arterial pressure in pulmonary hypertensive animals. RES-701-1 increased
pulmonary arterial pressure only in PH. Nitroglycerin depressed pulmonary
and systemic arterial tone equally well in controls and animals with PH.
Prostaglandin El produced a greater decrease in systemic arterial pressure
in pulmonary hypertensive than in normal animals, despite same effect on
pulmonary arterial pressure in both.
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PHARMACOLOGY - BASIC
ACE Inhibition (Quinapril) Modulates Central
Vasopressin in the Rat
ABSTRACfS
Attenuation of Myocardial Stunning by a Novel
Nonglucocorticoid 21-Aminosteroid Inhibitor of
Lipid Peroxidation
(ns vs 0). Conclusion: 3D reconstruction can improve spatial appreciation of
the shape of thrombi and accurately measure their volumes. This approach,
suitable for epivascular or transvenous imaging, could potentially be used to
study thrombus formation and lysis in research and clinical studies.
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Frank Muders, Miklos Palkovits 1, Karin Jandeleit 2, Dietmar Elsner, Udo Bahner 3,
Gunter A Riegger. University ofRegensburg, Germany: 3 University of Wurzburg,
Germany; 2 Medical Clinic ofHannover, Germany; 1 NIH Bethesda, USA
The beneficial effects of ACE inhibitors (ACE I) in heart failure and hyperten-
sion appear to be mediated not only by their influence on circulating ACE or
tissue ACE in the heart. Previous studies have also implicated the brain as
a possible site of actions for ACEI, e.g. by modifying central cardiovascular
mechanisms. Their effects on central vasopressin (AVP), which is an impor-
tant neurotransmitter in central cardiovascular regulation, are not known.
Following chronic administration of Quinapril (6 mglkgBW; 6 weeks,
p.o.) ACE activity (in vitro autoradiography using a specific ACE inhibitor
[1251]351A) was markedly inhibited in the thalamus (38%), hypothalamus
(37%). hypophysis (35%). cerebellum (36%) and plexus choroideus (20%)
suggesting Quinapril may cross the blood brain barrier after chronic treat-
ment. To study the influence of ACEI on central vasopressin, we deter-
mined the AVP content of 19 microdissected brain areas in rats treated with
Quinapril. Regarding the hypothalamic AVP-producing nuclei. increased AVP
levels could only been demonstrated in the paraventricular (PVN; Quinapril:
292 ± 197 vs. 2209 ± 568 pglmg protein of controls; p < 0.001). but not in the
supraoptic (SON) and the suprachiasmatic nucleus ISCN). Interestingly, vaso-
pressin synthesizing cells in the PVN project not only to the posterior pituitary
(like SON). but also to the lower brain stem and the spinal cord suggesting
an important role of the PVN in the regulation of the cardiovascular system.
Also, AVP content was sign. reduced in the median eminence (15643 ± 9240
vs. 28321 ± 4969, P < 0.001), where the hormone is mainly concentrated in
the hypothalamo-hypophysial tract. Furthermore, sign. changes were regis-
tered in the central amygdala, in the subcommissural organ and dorsal raphe
nucleus.
Conclusions: Autoradiographic study in vitro indicates that after chronic
treatment Quinapril is able to cross the blood brain barrier and suppress
central ACE activity. ACE inhibition with Quinapril markedly influences vaso-
pressin in important brain areas which are involved in central cardiovascular
regulation. Therefore, central modulatory effects of ACE inhibitor may con-
tribute to their overall therapeutic efficacy.
1901-111 I
Robert A. Kloner, James R. Sowers, Gerald F. DiBona, Margaret Cobb,
Manlee Wein, Michael Gaffney, ACCT Investigators. Heart Institute of the Hospital of
the Good Samaritan and University ofSouthern California, Los Angeles, CA
There is a lack of data on gender difference in response to the newer an-
tihypertensive medicines. The Amlodipine Cardiovascular Community Trial
was designed to determine the blood pressure (BP) response of patient sub-
groups with mild-moderate hypertension to amlodipine besylate monother-
apy (5-1 0 mg/day). After a 2 week placebo phase, patients received amlodip-
ine for a 4 week efficacy/titration phase followed by a 12 week maintenance
phase. Goal BP was defined as a decrease in diastolic BP by 10 mmHg or
more plus a diastolic BP of less than 90 mmHg. Baseline systolic BP in mmHg
was 153 ± 16 and 155 ± 16 and diastolic BP 101 ± 4 and 100 ± 4 for males
In = 702) and females (n = 382), respectively. Decreases in BP at 4 weeks
were greater in females than males for both systolic (-19 vs -15 mmHg, p
< 0.0001) and diastolic BP (-14 vs -12 mmHg, p < 0.0001). Results were
maintained at 12 weeks. Ninety-one percent of females achieved goal BP
compared to 83% of men (p = 0.001). The greater response to amlodipine by
women remained significant after adjusting for: age, weight, dose (mglkg),
baseline BP. and drug compliance (99% in both women and men). There was
no difference in decrease in systolic and diastolic BP for women on hormone
replacement (-18 and -14 mmHg) versus those not on hormone replace-
ment (-19 and -14 mmHg). Thus, hormone replacement in women did not
account for the gender difference in BP response. Women reported edema
Abel E. Moreyra, Robert S. Conway, Wen H. Chen, Windsor Tlng, John B. Kostis.
UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
Lipid peroxidation induced by oxygen free radicals has been implicated
in myocardial dysfunction during reperfusion. The effect of a new 21-
aminosteroid (Lazaroid, U74389G) that inhibits lipid peroxidation was stud-
ied in isolated, isovolumic rat hearts subjected to 20 min of normothermic
ischemia and subsequent repefusion for 30 min. Male Sprague-Dawley rats
(350-400 g) were randomized into three groups. Group 1 (Control; n = 13)
received vehicle before sacrifice and drug-free reperfusion, group 2 (Pretreat-
ment; n = 11) received 6 mglkg (iv) U74389G 30 min prior to sacrifice, and
group 3 (Reperfusion; n = 11) received 5 /LM U74389G in the reperfusion
solution. LV developed pressure (LVDP) and end-diastolic pressure ILVEDP)
were measured; maximum +dP/dt and the time constant of relaxation, Tau
(T). were calculated.
LVDP +dPldt LVEDP Tau
ImmHg) ImmHglsec) ImmHg) (msec)
Control group
Baseline 127 ± 6 2892 ± 127 5 ± 1 23 ± 1
30 min reperfusion 66 ± 5 1673 ± 140 30 ± 6 58 ±9
Pretreatment group
Baseline 122 ± 3 2893 ± 97 7 ± 1 24 ± 1
30 min reperfusion 112±3** 3171 ± 159** 14 ± 3* 28 ± 3*
Reperfusion group
Baseline 124 ± 4 2744 ± 77 5± 1 21 ± 1
30 min reperfusion 108 ± 5** 2785 ± 129** 14± 5* 32 ± 9*
*p < 0.05 VS. Control group, 30 min reperfusion; **p < 0.01 vs. Control group, 30 min
reperfusion
Conclusion: Whether administered before ischemia or during reperfusion
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Women Have a Higher Response Rate than Men
to the Antihypertensive Calcium Channel
Blocker Amlodipine
